From candidate selection through to proof-of-concept
Building a robust understanding of your API characteristics matched against your development programme goals, supports the efficient transition of drug products from candidate selection through to proof-of-concept. Starting @ 4pm (BST-UK), 11pm (ET), 8am (PT) and 6pm (BST-UK), 1pm (ET), 10am (PT)
Drug Product Strategies to Accelerate from Candidate Selection to Proof-of-Concept
This webinar will summarise how a fully integrated development plan can bring together the needs of the drug product team and the clinical development team.
The Integration of Drug Substance and Drug Product
This webinar will highlight how a fully integrated program can speed up transition from candidate selection to proof of concept and shorten the pathway to clinical development.
At a glance
Project Management at Quotient Sciences
Quotient is an innovative drug development and manufacturing partner supporting clients from candidate selection to commercial launch. With expertise in end-to-end Project Management and integrated project teams, we make drug development easier for our customers and dramatically reduce the time and cost of getting new medicines to patients.
Accelerating molecules through to Proof-of-Concept, with an integrated early development program
This webinar highlights how a fully integrated development plan can bring together the needs of the drug product team and the clinical development team.
Pharmaceutical Spray Drying to Overcome Poor Drug Solubility
Overcoming poor drug solubility is a common and challenging task facing the formulation scientist today.
Formulation strategies for poorly soluble molecules - Pharmaceutics and biopharmaceutics considerations
This presentation uses expert insight and case studies to explore formulation and solubility challenges and discuss the best strategies and technologies for advancing poorly soluble molecules, to deliver success.
Maximising Formulation Flexibility in First-in-Human Trials
This edition of OBN’s Digital Event series is being organized in collaboration with Quotient Sciences and will highlight how a fully integrated development plan can bring together the needs of the drug product team and the clinical development team.
The Role of Biopharmaceutics in Early Drug Development
This webinar discusses effective strategies being used by biotech and pharmaceutical companies to overcome biopharmaceutic challenges for small molecules in today’s drug development pipeline; and explores alternative approaches for accelerating your early development plan.